Anthera Pharmaceuticals, Inc.
ANTH
$0.0001
$0.000.00%
OTC PK
| 03/31/2018 | 12/31/2017 | 09/30/2017 | 06/30/2017 | 03/31/2017 | |
|---|---|---|---|---|---|
| Net Income | 31.08% | 25.51% | 61.72% | 102.18% | 4.43% |
| Total Depreciation and Amortization | 257.78% | 40.00% | -56.84% | 116.22% | -37.50% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -99.17% | 52.58% | -156.04% | -665.05% | 50.81% |
| Change in Net Operating Assets | 62.25% | 409.82% | 48.22% | -264.32% | -2,788.69% |
| Cash from Operations | 34.53% | 48.81% | 57.72% | 10.72% | -33.87% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.48% | 508.70% | -46.52% | -76.57% | 767.36% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5.48% | 655.56% | -94.10% | -76.57% | 767.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3,183.77% | 66.91% | -224.69% | -1.32% | 97.90% |